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Abstract 
There are a number of existing classifications and staging schemes for carcinomas, 
one of the most frequently used being the TNM classification. Such classifications 
represent classes of entities which exist at various anatomical levels of granularity. 
We argue that in order to apply such representations to the Electronic Health Records 
one needs sound ontologies which take into consideration the diversity of the domains 
which are involved in clinical bioinformatics. Here we outline a formal theory for 
addressing these issues in a way that the ontologies can be used to support inferences 
relating to entities which exist at different anatomical levels of granularity. Our case 
study is the colon carcinoma, one of the most common carcinomas prevalent within 
the European population.  
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1. Introduction 
Over 40 carcinomas have been analyzed in terms of the Tumor, Node and Metastasis (TNM) 
classification, which classifies a carcinoma on the basis of the extent of its spread, lymph 
node involvement and metastasis and which is used for staging the relevant guidelines for the 
management of patients [1,2]. An automated ontology-based system designed to establish for 
each specific pathology the appropriate TNM class would first need to register the anatomical 
structures (colon, lung, prostate, etc.) involved. Unfortunately, the Electronic Health Records 
(EHRs) often use anatomical terms different from those used in the TNM classification. Thus 
the systems need to provide a methodology by which different anatomical terms can be 
related to the corresponding TNM anatomical entity. In addition to anatomy, however, the 
system would need to take account also of pathologies, cellular characteristics, and other 
salient features. For an efficient integration with EHRs, the ontology system would need to 
represent such features explicitly and in such a way that it supports inferences drawing not 
only on EHR data but also on biological databases dealing with the mutations and protein 
variants which are involved in the different stages of carcinoma development. 
 Clinical bioinformatics is a field based on the integration and interpretation of life-
science data at many levels of granularity, from the coarser (clinical) levels of signs, 
symptoms, radiological findings, to the finer levels of genotype-phenotype expression and 
associated molecular pathways. To achieve this end, an ontological theory is required that is 
able to deal with such a diversity among the entities involved. Here, we present a theory of the 
needed sort, which is designed to do justice to the fact that the anatomical entities as 
represented within an anatomy reference ontology can be used to support the drawing of  
inferences relating to the anatomical and pathological data present within the EHRs of 
individual patients. We use the example of colon carcinoma as a case study and present an 
extension to our previous work, where using our own ontology of relations we integrated 
terms in Gene Ontology1 with the database of protein mutations present within Swissprot2 
[3,4,5]. 
2. Formalization 
Classes and individuals 
As anatomy reference ontology we have selected the Foundational Model of Anatomy 
(FMA),3 which is a representation of canonical anatomy. [6] Thus colon, as it appears within 
the FMA, represents a normal colon – where in the present context of course we need to deal 
also with abnormal colons. The FMA is however designed as a reference ontology that can 
serve as a basis also for non-canonical anatomy. In the correspondingly extended FMA 
(EFMA) we have both: 
abnormal colon is_a colon 
normal colon is_a colon 
We distinguish between colon carcinoma disease and the associated pathological structure. 
Only the latter falls within the domain of EFMA. For the latter we have:  
colon carcinoma pathological structure is_a carcinomatous pathological structure 
colon carcinoma pathological structure part_of abnormal colon 
colon carcinoma pathological structure part_of colon 
On the reading of ‘part_of ’ adopted by us here with our own ontology for relations, A part_of 
B means that every instance of A is an instance-level part of some instance of B (this reading 
is used in the FMA in conjunction with the reading of ‘part_of ’ described in Smith Rosse 
Medinfo paper Every colon carcinoma is part of some colon, but not every colon has some 
colon carcinoma as part. We also have  
abnormal colon transformation_of normal colon 
where A transformation of B holds where A and B are distinct classes which are such that for 
any instance a of A and any time t, there is some earlier time t1, at which a an instance of B. 
(We leave aside here those abnormalilities which are abnormal from the start because they are 
present abnormally within the fetus [7].) We further have: 
carcinomatous colon is_a abnormal colon 
carcinomatous colon transformation_of normal colon 
 
Parthood and location relations 
The FMA includes parthood relations such as: 
ascending colon part_of colon 
mucosa of colon part_of wall of colon part_of colon 
Because the parthood relation implies a location relation, [8] we also have: 
region of ascending colon located_in region of colon  
region of mucosa of colon part_of region of wall of colon part_of region of colon 
 








A carcinomatous pathological process demands in every case some anatomical entity as its 
bearer. Thus  
carcinomatous pathological function in ascending colon born_by ascending colon 
T1 stage carcinomatous pathological function in ascending colon born_by mucosa of 
ascending colon 
We also have: 
carcinomatous pathological process in ascending colon has_participant ascending colon 
T1 stage carcinomatous pathological processin ascending colon has_participant mucosa of 
ascending colon 
Creation relation between process and anatomical entity 
We have dealt with relations between anatomical entities and the associated biological 
processes elsewhere. [9] One of them is the creation relationship. A process creates a 
substance when the substance did not exist before the initiation of the process and exists after 
the process has started. It is not necessary that a single process brings a substance into being 
by itself. It is also not necessary that each process brings a substance into being. However, in 
case of carcinoma of colon, the pathology leads to a pathological structure, though not always. 
Thus, 
carcinomatous pathological process in ascending colon creates carcinomatous structure in 
ascending colon 
T1 stage carcinomatous pathological process in ascending colon creates T1 stage 
carcinomatous structure in ascending colon 
The pathological structure is part of the organ affected by the pathology. There is also a 
parthood relation between a pathological structure and the pathological organ. Thus, 
carcinomatous structure in ascending colon part_of carcinomatous ascending colon 
region of carcinomatous structure in ascending colon part_of region of carcinomatous 
ascending colon 
T1 stage carcinomatous structure in ascending colon part_of carcinomatous mucosa of 
ascending colon 
Anatomical levels of granularity 
Every anatomical entity in the FMA has a default level of granularity. For example, colon has 
an organ level of granularity; ascending colon has an organ part level of granularity. We then 
have a mapping ‘gran’ from FMA terms to levels of granularity, such that for example: 
gran(colon) = organ 
and  
gran(ascending colon) = organ part 
Finer levels of granularity – of atoms, molecules and subcellular organelles – are also needed 
for our carcinoma ontology in order that we can represent processes at the cellular level, 
markers like p53 and the various mutant proteins associated with colon carcinoma and 
represented in the modSNP database of Swissprot. 
TNM Classification 
TNM classification classifies carcinomas on the basis of the extent of tumor spread, lymph 
nodes involved and metastasis. There are certain levels of granularity in anatomy which apply 
to each of the TNM classes. We have dealt with these in more detail in [10]. We apply them 
here to the entities which are involved in a specific T, N or M class for colon carcinoma. 
However, anatomy is not the only partition which is salient to TNM classes. Other partitions, 
for example pathogenesis and number of lymph nodes involved are also taken into 
consideration. Our formalism represents the levels of granularity and mentions the other 
partitions involved. 
Table 1. Anatomical levels of granularity for TNM classification 
TNM Explanation as stated in the TNM 
Classification by the respective 
Cancer Societies 
Level of Granularity Other 
partitions 
TX Primary tumor cannot be assessed –  
T0 No evidence of primary tumor –  
Tis Carcinoma in situ: intraepithelial or 
invasion of the lamina propria 
Intraepithelial cell (C); Epithelium & 
lamina propria (ORP/MPOT) 
 
T1 Tumor invades submucosa Submucosa of colon (ORP/MPOT)  
T2 Tumor invades muscularis propria Muscularis mucosa of colon 
(ORP/MPOT) 
 
T3 Tumor invades through the muscularis 
propria into the subserosa, or into 
nonperitonealized pericolic or perirectal 
tissues 
Subserosa of colon (ORP/MPOT), 





T4 Tumor directly invades other organs or 
structures, and/or perforates visceral 
peritoneum 
organs (OR-E), visceral peritoneum (ORP) path of 
invasion 
(pathogenesis) 
NX Regional nodes cannot be assessed –  
N0 No regional lymph node metastasis –  
N1 Metastasis in 1 to 3 regional lymph 
nodes 
lymph node (ORP), collection of lymph 
nodes (ORP-C) 
number 
N2 Metastasis in 4 or more regional lymph 
nodes 
lymph node (ORP), collection of lymph 
nodes (ORP-C) 
number 
MX Distant metastasis cannot be assessed –  
M0 No distant metastasis –  
M1 Distant metastasis ORG  
ORG = Organism; OR = Organ; OR-E = Organ (external to the original organ); ORP = 
Organ Part; MPOT = Maximal Portion of Tissue (equivalent to organ part but in a different 
partition); C = Cell; SC = Subcellular 
TNM Classification and Staging  
Various cancer societies have proposed different staging criteria for carcinomas, which apply 
at two different levels. Among those carcinomas for which a TNM classification exists, stages 
are not classified other than by means of the relevant TNM classes. The corresponding 
management guidelines are then based on these classes, so that for example there is a specific 
management protocol for the T1N2M0 class of bladder carcinomas. However, in case of some 
carcinomas, including colon, an additional grouping is imposed upon the TNM classification 
by the American Joint Committee on Cancer (AJCC). For example, stage IIIa of colon 
carcinoma includes T1N1M0 and T2N1M0. The management protocols applicable to these 
TNM classes are similar and thus are usually specified in terms of stage IIIa. This means that 
the ontological representation of carcinomas like colon is incomplete if the stages of 
carcinoma defined over the TNM classes are not included, and therefore, we provide those 
representations in our ontology also. 
Table 2: Definitions for AJCC staging for colon carcinoma 
Stage Clinical definition Logical definition 
0 Tis, N0, M0 Tis & N0 & M0 
I T1, N0, M0; T2, N0, M0 (T1 or T2) & N0 & M0 
IIa T3, N0, M0 T3 & N0 & M0 
IIb T3, N0, M0 T4 & N0 & M0 
IIIa T1, N1, M0; T2, N1, M0 (T1 or T2) & N1 & M0 
IIIb T3, N1, M0; T4, N1, M0 (T3 or T4) & N1 & M0 
IIIc Any T, N2, M0 N2 & M0 
IV Any T, Any N, M1 M1 
 
Other staging systems 
There are other staging systems for colon carcinoma, for example, the Modified Asler-Coller 
(MAC), Duke’s and so on. These take into consideration entities similar to the ones for TNM, 
for example, invasion of mucosa or submucosa and so on, and they will not be considered 
here. According to the kinds of cells predominantly present within the pathology, the different 
classes are designated as follows: adenomatous, mucinous, signet-ring, scirrhous and 




In addition to the features taken account of in the TNM classification, there are also several 
other features which are important in order to understand the prognostic factors and treatment 
planning for carcinomas. They are primarily related to finer levels of granularity. 
Table 3: Pathologic features, their involvement in processes and their anatomical levels of 
granularity 
Pathologic features Process involved Level of 
granularity 
vascular endothelial growth factor angiogenesis M 
reverse transcriptase lymph node micrometastasis M 
radial margins of carcinomatous 
structure 
carcinoma penetration OR 
degree of tumor differentiation carcinoma penetration and metastasis SC, C 
mucin producing cancer cells peritoneal seeding SC, C 
aneuploidy karyotypic and phenotypic heterogeneity SC 
proliferation index (the sum of the 
percentage of cells in S phase plus 
those in G(2)/M phase) 
karyotypic and phenotypic heterogeneity C 
Clinical Genomics Model in HL7 v3 
The above formalization between various entities need to connected to EHRs in order to be 
applicable to individual patient attributes, Health Level 7 (HL7)4 provides standards for the 
exchange, management and integration of data that supports clinical patient care. There are 
various domains represented within HL7 and each of those has a Domain Message 
Information Model (DMIM), based on which various Refined Message Information Models 
(RMIMs) are built. 
 The clinical genomics domain encapsulates various types of genomic data relating to a 
pair of alleles (a locus-genotype) including sequencing, expression and proteomics data. It 
also incorporates emerging standard formats like BSML5 (Bioinformatic Sequence Markup 
Language) and MAGE-ML6 (Microarray and Gene Expression Markup Language).  
 The main classes within the clinical genomics Genotype DMIM include genotype 
attributes, gene associated observation, Individual allele, sequence (recursive class), sequence 
variation property and expression. These classes represent entities present at the subcellular 
and molecular levels of granularities and are parts of the cell where they are present. 
 There are many pathological features which are present at these finer levels of 
granularity and usage of clinical genomics model would help connect to patient data at those 
levels of granularity for the purposes of inferences to be drawn on EHRs for carcinoma 
classifications. 
 








The main advantages of assigning levels of granularity to the entities with parthood and 
dependence relations are: 
a. Entities within clinical bioinformatics are present at different levels of granularity and 
various annotations related to genotypes and their expression as phenotypes are associated 
with them. The interpretation of those annotations are relevant only at the respective 
granular levels. 
b. Inferences derived from data pertaining to the entities and their annotations depend on the 
granularity levels of the entities involved. For example, if we know that a mutation exists 
at the subcellular level within a collection of cells then this is not enough to be infer a 
diagnosis of carcinoma. The TNM classes involve entities clearly distinguished on the 
basis of anatomical entities existing at various granularity levels. 
c. The formalism provides a basis of relations that obtain between substances, functions, 
processes and their attributes, which are useful to represent relations between pathological 
structures, anatomical structures and pathological processes applicable to carcinomas [10]. 
 
The formalism has been applied in the case of Colon carcinoma representing entities at 
coarser levels of granularity applicable principally for medical informatics and representing 
entities at finer levels of granularity applicable principally for bioinformatics. [3, 4] We 
believe that it is a valuable first step towards bridging the gaps in representing entities for 
clinical bioinformatics in the domain of oncology. 
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